In recent decades, immunotherapy has transformed cancer treatment, offering effective options for diseases once considered ...

Nov. 11, 2024 — Researchers have discovered a new way in which RAS genes, which are commonly mutated in cancer, may drive tumor growth beyond their well-known role in signaling at the cell surface.

Antoni Vilaseca Cabo, MD, discusses the rationale behind the phase 1 study evaluating the safety and efficacy of TAR-210 in patients with FGFR-altered high- and intermediate-risk non–muscle invasive ...

In an interview, Antoni Vilaseca Cabo, MD, discussed the clinical activity of TAR-210 in patients with non-muscle invasive ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that combining pembrolizumab, ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators ... and chemotherapy as a first-line therapy for bladder and prostate small cell cancers.

Huntsman Cancer Institute’s Urologic Cancers Program provides comprehensive, compassionate, state-of-the-art care for people with these cancers. Our experts treat and diagnose all types of urologic ...

According to the authors, "These results support the use of Benmelstobart plus anlotinib as a new first-line treatment for advanced RCC.” ...

New research into a chemical produced by a caterpillar fungus that has shown promise as a possible cancer treatment has ... thousands of genes in multiple cell lines. The research compared the ...

In a recent Science article, researchers unveiled a method to kill cancer cells by sticking two proteins together to activate a gene that signals for cell death. This new method is helpful for ...